Related Experiment Video
Updated: Apr 27, 2026

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
Published on: July 28, 2023
Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate
Mark A Underwood1, Jennifer Arriola2, Colin W Gerber2
1Department of Pediatrics, University of California, Davis, Sacramento, California.
Insights
Probiotic Bifidobacterium longum subsp. infantis (B. infantis) reduced necrotizing enterocolitis (NEC) in a rat model. This beneficial effect was observed despite no significant changes in the cecal microbiota composition.
Area of Science:
- Gastroenterology
- Microbiology
- Neonatal Research
Background:
- Necrotizing enterocolitis (NEC) is a severe condition in premature infants.
- Probiotics are known to reduce NEC risk.
- The specific role of Bifidobacterium longum subsp. infantis (B. infantis) in NEC requires further investigation.
Purpose of the Study:
- To evaluate the efficacy of B. infantis in an established rat model of NEC.
- To assess the impact of B. infantis on inflammatory markers and gut barrier function in NEC.
- To analyze the cecal microbiota composition following B. infantis administration.
Main Methods:
- Rat pups were divided into dam-fed, formula-fed, and formula-fed with B. infantis groups.
- Experimental NEC was induced via hypoxia and cold stress.
- Ileal tissue and cecal contents were analyzed for pathology, inflammatory mediators, antimicrobial peptides, and bacterial 16S rRNA sequences.
Main Results:
- B. infantis administration significantly decreased NEC incidence and reduced key inflammatory mediators (Il6, Cxcl1, Tnfa, Il23, iNOS).
- Expression of antimicrobial peptides Reg3b and Reg3g was also decreased.
- No significant differences in cecal microbiota composition were found between formula-fed and B. infantis-supplemented groups, with low Bifidobacteria detection.
Conclusions:
- B. infantis attenuated NEC-associated inflammation in the rat model.
- The study highlights the anti-inflammatory effects of B. infantis.
- Significant microbial dysbiosis variability precluded determining the microbiota's precise role in experimental NEC.
Background:
Probiotics decrease the risk of necrotizing enterocolitis (NEC). We sought to determine the impact of Bifidobacterium longum subsp. infantis (B. infantis) in the established rat model of NEC.
Methods:
Rat pups delivered 1 d prior to term gestation were assigned to one of three groups: dam fed (DF), formula fed (FF), or fed with formula supplemented with 5 × 10(6) CFU B. infantis per day (FF+Binf). Experimental pups were exposed to hypoxia and cold stress. Ileal tissue was examined for pathology and expression of inflammatory mediators, antimicrobial peptides, and goblet-cell products. Ceca were assessed for bacterial composition by analysis of the 16S rRNA sequence.
Results:
Administration of B. infantis significantly reduced the incidence of NEC, decreased expression of Il6, Cxcl1, Tnfa, Il23, and iNOS, and decreased expression of the antimicrobial peptides Reg3b and Reg3g. There was significant microbial heterogeneity both within groups and between experiments. The cecal microbiota was not significantly different between the FF and FF+Binf groups. Bifidobacteria were not detected in the cecum in significant numbers.
Conclusion:
In the rat model, the inflammation associated with NEC was attenuated by administration of probiotic B. infantis. Dysbiosis was highly variable, precluding determination of the precise role of the microbiota in experimental NEC.
Related Concept Videos
Development of Human Microbiota
Bacterial Gastroenteritis
Microbiota of the Large Intestine
Development of the Oral Microbiota
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Microbiota of the Stomach and Small Intestine

